ANIKORA Trademark

Trademark Overview


On Wednesday, July 27, 2022, a trademark application was filed for ANIKORA with the United States Patent and Trademark Office. The USPTO has given the ANIKORA trademark a serial number of 97523022. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 9, 2024. This trademark is owned by CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd.. The ANIKORA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the ...
anikora

General Information


Serial Number97523022
Word MarkANIKORA
Filing DateWednesday, July 27, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBaoshan, Shanghai 201908
CN

Party NameCTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBaoshan, Shanghai 201908
CN

Trademark Events


Event DateEvent Description
Friday, May 12, 2023ASSIGNED TO EXAMINER
Saturday, July 30, 2022NEW APPLICATION ENTERED
Thursday, August 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 12, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, May 12, 2023SUSPENSION LETTER WRITTEN
Friday, May 12, 2023LETTER OF SUSPENSION E-MAILED
Thursday, May 18, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, October 16, 2023ASSIGNED TO LIE
Monday, October 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 6, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 6, 2023SUSPENSION LETTER WRITTEN
Monday, November 6, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, February 7, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, February 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 6, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2024NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 8, 2024NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 4, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 4, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, June 4, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 4, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED